year
111Category: | Pharmaceuticals and Biochemicals |
|
|
CAS NO: | 643-22-1 | ||
EC NO: | 211-396-1 | ||
Molecular Formula: | C55H101NO14 | ||
Molecular Weight: | 1000.3887 | ||
Specification: | |||
InChI: | InChI=1/C55H101NO14/c1-15-17-18-19-20-21-22-23-24-25-26-27-28-29-30-31-43(57)68-47-41(56(12)13)32-36(4)65-52(47)70-50-38(6)46(69-44-34-54(10,64-14)49(60)40(8)66-44)39(7)51(61)67-42(16-2)55(11,63)48(59)37(5)45(58)35(3)33-53(50,9)62/h35-42,44,46-50,52,59-60,62-63H,15-34H2,1-14H3/t35-,36-,37+,38+,39-,40+,41+,42-,44+,46+,47-,48-,49+,50-,52+,53-,54-,55-/m1/s1 | ||
Synonyms: | Erythromycin stearate [BAN:JAN];Abboticine;Bristamycin;CCRIS 1504;Dowmycin E;Eratrex;Erythrocin stearate;Erythromycin stearate (salt);Erythromycin steraric acid salt;Ethril;Ethril 250;Ethril 500;HSDB 4178;Meberyt;NCI-C55674;OE 7;Octadecanoic acid, compd. with erythromycin (1:1);Pfizer-E;Qidmycin;Stearic acid, compd. with erythromycin (1:1);UNII-LXW024X05M;Wyamycin S;Erythromycin octadecanoate (salt);Erythromycin, stearate (salt);octadecanoic acid - (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (1:1) (non-preferred name);(2S,3R,4S,6R)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl octadecanoate (non-preferred name); | ||
Molecular Structure: |